SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-020186
Filing Date
2020-02-13
Accepted
2020-02-13 16:15:33
Documents
4
Period of Report
2020-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207916d1_8k.htm 8-K 33927
2 EXHIBIT 4.1 tm207916d1_ex4-1.htm EX-4.1 101384
3 EXHIBIT 10.1 tm207916d1_ex10-1.htm EX-10.1 61278
4 EXHIBIT 99.1 tm207916d1_ex99-1.htm EX-99.1 12648
  Complete submission text file 0001104659-20-020186.txt   210820
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 20610721
SIC: 2836 Biological Products, (No Diagnostic Substances)